Here's What Boosted CVS Health Corporation (CVS) in Q1
PGIM Jennison Health Sciences Fund recently released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Cvs Health Corp (CVS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 17,682,374 | $1,197,980,839 | -10% | 4.18% |
| 2. | Glenview Capital Larry Robbins | 11,946,799 | $809,395,632 | 19.9% | |
| 3. | Citadel Investment Group Ken Griffin | 6,260,250 | $424,131,938 | -2% | 0.08% |
| 4. | Harris Associates Natixis Global Asset Management | 5,995,818 | $406,216,698 | +6% | 0.68% |
| 5. | Holocene Advisors Brandon Haley | 5,928,174 | $401,633,789 | +125% | 1.17% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $63.70 | 1,570 | $100,009.00 | 12,007 | 2025-06-05 | Filing | |
| $66.70 | 30,000 | $2,001,000.00 | 39,356 | 2025-02-18 | Filing | |
| $53.88 | 1,000 | $53,879.00 | 21,630 | 2024-05-02 | Filing | |
| $54.49 | 9,181 | $500,293.81 | 9,356 | 2024-05-02 | Filing | |
| $70.47 | 2,000 | $140,930.00 | 20,630 | 2023-11-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.67 | 150,000 | $10,000,710.00 | 8,196,799 | 2025-05-06 | Filing | |
| $67.99 | 96,999 | $6,595,272.41 | 8,346,799 | 2025-05-05 | Filing | |
| $67.37 | 1,226,933 | $82,654,672.72 | 8,443,798 | 2025-05-05 | Filing | |
| $69.66 | 373,776 | $26,035,591.55 | 9,670,731 | 2025-05-02 | Filing | |
| $68.38 | 222,556 | $15,218,980.18 | 10,044,507 | 2025-05-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 592,385 | $40,862,746 | 0.59% | |
| 2. | 565,588 | $39,014,495 | 3.05% | |
| 3. | 405,360 | $27,763,106 | 1.98% | |
| 4. | 189,431 | $13,066,950 | 0.43% | |
| 5. | 48,751 | $3,362,873 | 0.11% |
News See All
CVS Health Corporation (CVS) Outpaces Broader Market with Strong 2025 Rally
Following a challenging year in 2024, CVS Health Corporation (NYSE:CVS) appears to be making progress toward a recovery.
15 Best Dividend Stocks of 2025
After underperforming the market in seven of the past eight years, the Morningstar Dividend Leaders Index has made a strong comeback in 2025.
CVS Health Corporation (CVS): A Bull Case Theory
We came across a bullish thesis on CVS Health Corporation on Microcapexpert’s Substack. In this article, we will summarize the bull’s thesis on CVS.
This Under-the-Radar Healthcare Stock Could Be a Solid Income Play
Even during economic downturns, people continue to rely on medications, essential consumer products, and affordable local healthcare.
Wells Fargo Remains Bullish on CVS Health (CVS) With an $84 PT
CVS Health Corporation (NYSE:CVS) is one of the 13 Most Undervalued Retail Stocks to Buy Right Now.
CVS Health Corporation (CVS) Surged on Solid Returns and Better-Than-Expected Guidance
Ariel Investments, an investment management company, released its “Ariel Global Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
13 Most Undervalued Retail Stocks to Buy Right Now
On June 12, CNBC reported that new results from an AlixPartners survey show that most retail executives anticipate President Trump to walk back "reciprocal" tariffs on India, Vietnam, the EU, and the ...
CVS Health Corporation (CVS): Jim Cramer Says You Don't Want Them Buying The Wrong Robots
We recently published a list of Jim Cramer Discusses Melting Trade Tensions & These 12 Stocks.
CVS Health (CVS) Maintains Overweight Rating at Cantor Amid Membership Data Discrepancies
Cantor Fitzgerald analysts reaffirmed their price target of $71 and Overweight rating on CVS Health Corporation (NYSE:CVS) on June 4.
Billionaire Hedge Funds
